Sudarshan Chemical Appoints Amit Deshpande as Company Secretary & Compliance Officer
Sudarshan Chemical Industries Limited's Board approved Q2 FY27 results. Mr. Amit Deshpande was appointed Company Secretary, Compliance Officer, and Nodal Officer, effective November 6, 2026. Key managerial personnel were authorized for disclosures. The trading window reopens November 9, 2026.
The appointment of a Company Secretary and Compliance Officer is a significant corporate governance event, impacting internal controls and external communication, thus having a medium-term impact.
The announcement primarily concerns routine financial reporting and a key management appointment, with no immediate positive or negative financial impact indicated.
Sudarshan Chemical Industries Limited announced the outcome of its Board Meeting held on November 6, 2026. The Board approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026.
In a significant management update, the Board also approved the appointment of Mr. Amit Deshpande as the Company Secretary and Compliance Officer, Nodal Officer, and Key Managerial Personnel of the Company. This appointment is effective from November 6, 2026, and is in addition to his existing role as General Counsel and Senior Management Personnel.
The Board also approved changes in authorization for determining the materiality of events and making disclosures, designating key managerial personnel including Mr. Rajesh Rathi (Chairman and Managing Director), Mr. Ashish Vij (Whole-Time Director), Mr. Nilkanth Natu (Chief Financial Officer), and Mr. Amit Deshpande (General Counsel and Company Secretary) for these responsibilities.
Furthermore, the trading window for dealing in the company's securities will open on Monday, November 9, 2026, 48 hours after the declaration of the financial results.
The Board Meeting commenced at 12:00 p.m. (IST) and concluded at 2:00 p.m. (IST).
What to do with a filing like this
Sudarshan Chemical Industries Limited filed this with the NSE as a statutory disclosure, categorised under board meeting. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sudarshan Chemical Industries Limited. Read the original for the full detail.